Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective.

CONCLUSION: This review discusses the biosimilars, their regulation globally and their difference from generics from ophthalmic perspective.
PMID: 31315829 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - July 16, 2019 Category: Opthalmology Authors: Sharma A, Kumar N, Kuppermann BD, Bandello F, Loewenstein A Tags: Br J Ophthalmol Source Type: research